EarlyCDT-Lung

The EarlyCDT® Lung test detects the presence of autoantibodies generated by the body’s immune system, a natural defense against cancer cells. This aids in the early detection of lung cancer in high-risk patients.

Leading Precision Medicine In South East Asia (Sea)

Pathomics Health focuses on advanced precision medicine diagnostics and digital healthcare solutions to provide patients access to better outcome.

Leading Precision Medicine In South East Asia (Sea)

Pathomics Health focuses on advanced precision medicine diagnostics and digital healthcare solutions to provide patients access to better outcome.

Our Mission

Advancing Diagnostics & Digital Health Solutions for Better Health

We focus on advanced precision medicine diagnostics and digital healthcare solutions.

Our Vision

Universal Accessibility to Affordable Precision Diagnostics & Screening

We offer an innovative, scalable and cost-effective advanced diagnostics platform, combining with cutting-edge technology and design to help patients and individuals to improve their health.

Our Commitment

We are committed in delivering high-quality and yet affordable diagnostics solutions to meet the diverse needs of our customers. Contact us today to find out more about our service offerings.

Company Milestones - Driving Excellence Since 2017

Our Laboratories

Investor Relations

Pathomics Health takes a proactive approach in managing its Investor Relations to cultivate strong relationships and effective communication with its investors. This involves regular engagement with stakeholders to foster trust and provide timely updates on financial performance, market conditions, and strategic initiatives. Through transparent and consistent communication, the company aims to enhance investor understanding, confidence, and engagement.